Mathematical Analysis of the Probability of Spontaneous Mutations in HIV-1 Genome and Their Role in the Emergence of Resistance to Anti-Retroviral Therapy
- 1 Kobri El Koba Medical Complex, Cairo, Egypt
Abstract
High mutability of HIV is the driving force of antiretroviral drug resistance, which represents a medical care challenge. The proposed model represents a mathematical analysis of the mutability of each gene in the HIV-1 genome. It depends on a linear relation wherein the probability of spontaneous mutations emergence is directly proportional to the ratio of the gene length to the whole genome length. The mathematical analysis shows that tat , vpr and vpu are the least mutant genes in HIV-1 genome, and protease PROT gene is the least mutant gene component of polymerases POL . Accordingly, tat , vpr and vpu are the best candidates for HIV-1 recombinant subunit vaccines or as a part of “prime and boost” vaccine combinations. Also, the protease inhibitor-based regime represents a high genetic barrier for HIV to overcome.
- Iyidogan, P. and Anderson, K.S. (2014) Current Perspectives on HIV-1 Antiretroviral Drug Resistance. Viruses, 6, 4095-4139. https://doi.org/10.3390/v6104095
- Rambaut, A., Posada, D., Crandall, K.A. and Holmes, E.C. (2004) The Causes and Consequences of HIV Evolution. Nature Reviews Genetics, 5, 52-61. https://doi.org/10.1038/nrg1246
- Davies, J. and Davies, D. (2010) Origins and Evolution of Antibiotic Resistance. Microbiology and Molecular Biology Reviews, 74, 417-433. https://doi.org/10.1128/MMBR.00016-10
- Robertson, D.L., Hahn, B.H. and Sharp, P.M. (1995) Recombination in AIDS Viruses. Journal of Molecular Evolution, 40, 249-259. https://doi.org/10.1007/BF00163230
- Petropoulos, C. (1997) Retroviral Taxonomy, Protein Structures, Sequences, and Genetic Maps. Retroviruses Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 757-805.
- Cane, P., Chrystie, I., Dunn, D., Evans, B., Geretti, A.M., Green, H., et al. (2005) Time Trends in Primary Resistance to HIV Drugs in the United Kingdom: Multicentre Observational Study. British Medical Journal, 331, 1368. https://doi.org/10.1136/bmj.38665.534595.55
- Yebra, G. and Holguin, A. (2010) Epidemiology of Drug-Resistant HIV-1 Transmission in Naive Patients in Spain. Medicina Clinica, 135, 561-567. https://doi.org/10.1016/j.medcli.2009.09.029
- Yalçinkaya, T. and Köse, S. (2014) Investigation of HIV-1 Primary Drug Resistance Mutations in Antiretroviral Therapy-Naive Cases. Mikrobiyoloji Bulteni, 48, 585-595. https://doi.org/10.5578/mb.8321
- Abar, A.E., Jlizi, A., Darar, H.Y., Kacem, M.A.B.H. and Slim, A. (2012) HIV-1 Drug Resistance Genotyping from Antiretroviral Therapy (ART) Naïve and First-Line Treatment Failures in Djiboutian Patients. Diagnostic Pathology, 7, 138. https://doi.org/10.1186/1746-1596-7-138
- Mansky, L.M. and Temin, H.M. (1995) Lower in Vivo Mutation Rate of Human Immunodeficiency Virus Type 1 than that Predicted from the Fidelity of Purified Reverse Transcriptase. Journal of Virology, 69, 5087-5094.
- Cuevas, J.M., Geller, R., Garijo, R., López-Aldeguer, J. and Sanjuán, R. (2015) Extremely High Mutation Rate of HIV-1 in Vivo. PLoS Biology, 13, e1002251. https://doi.org/10.1371/journal.pbio.1002251
- Paydary, K., Khaghani, P., Emamzadeh-Fard, S., Alinaghi, S.A.S. and Baesi, K. (2013) The Emergence of Drug Resistant HIV Variants and Novel Anti-Retroviral Therapy. Asian Pacific Journal of Tropical Biomedicine, 3, 515-522. https://doi.org/10.1016/S2221-1691(13)60106-9